Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

But not enough patients visited VillageMD’s doctors, and the business is now up for sale. Brewer exited in September 2023 and Walgreens last year took a $5.8bn after-tax charge related to VillageMD, ...

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Wall Street's main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

Sycamore Partners is planning a three-way split of Walgreens Boots Alliance if a deal to take the struggling pharmacy chain ...

In the waning days of the Biden administration, the Labor Department added ovarian, uterine, cervical, and breast cancer coverage for wildland firefighters. It’s unclear whether the new protections ...

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

Deutsche Bank believes the hype over a Sycamore buyout and subsequent breakup has gone too far, and puts the deal at risk.

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.

Deutsche Bank downgraded Walgreens Boots Alliance (WBA) to Sell from Hold with a price target of $9, down from $11. The firm says the reports ...

Deutsche Bank analyst George Hill downgraded Walgreens stock to Sell from Hold and reduced his price target to $9 from $11 in ...